Mark Easley, MD, Chief, Duke University Foot and Ankle Division said, “With my first patient treated, I’m impressed with the experience and outcome from using the RedPoint PSI and Lapiplasty® technologies. It’s exciting to have these technologies available for the first time where I can visualize the patient’s deformity in 3D, develop and simulate a surgical plan, and create cut guides specific to the patient’s unique anatomy, all before stepping into the operating room.”*
The RedPoint PSI software and systems will be integrated with Treace’s instrumentation and implant systems in 2023, with commercial introduction of patient-specific products expected in the second half of 2024.
To receive updates please contact CS@Treace.net